Furthermore, when preclinical cancer develops, effector T cells continuously encounter neoantigens, along with immunosuppressive cytokines e.g., IL-10 and TGF-β, which induces T cell exhaustion in the tumour microenvironment (215) representing a mechanism by which cancer escapes immune control and grows aggressively (216). Here, TGFB1 is linked to cancer.